Manufacturer record
SB Lifesciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by SB Lifesciences (Uttarakhand) were declared Not of Standard Quality between September 2023 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SL-508, Azilium 200 Suspension (exp Jan 2026). FDA Lab, Mumbai (CDSCO lab) found it not of standard quality: Content of Anhydrous Azithromycin. Listed in the June 2025 alert.
Records by type
3 records linked to SB Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Azilium 200 Suspension | Batch SL-508Mfg Feb 2024 · Exp Jan 2026 | Content of Anhydrous AzithromycinOther | FDA Lab , MumbaiCDSCO lab | Jun 2025 |
| Paracetamol Chlorpheniramine Maleate & Phenylephrine Hydrochloride Suspension (GBCOLD) | Batch SL-247Mfg Aug 2023 · Exp Jul 2025 | Assay of Phenylephrin e Hydrochlorid eAssay | CDL KolkataCDSCO lab | Sep 2023 |
| Mefenamic Acid & Paracetamol Suspension (Varnmic- P) | Batch SL-234Mfg Aug 2023 · Exp Jul 2025 | Assay of Mefenamic AcidAssay | CDL KolkataCDSCO lab | Sep 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.